Cd8 as an inhibitor of the cellular immune system
CA 2308463 A1 · Owner: Jakobsen, Bent Karsten · Inventors: Gerth, Ulrich Conrad; Sewell, Andrew Kelvin; Gao, George Fu
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method for inhibiting CTL activity is described in which soluble CD8 is used as the inhibitor. The method is particularly useful for immunosuppressive therapy in which inhibition of CTL activity is desirable for example in , patients undergoing transplantation.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 28, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 28, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 28, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.